Nurosym vs Vagustim — Side-by-Side Comparison

Nurosym vs Vagustim (2026)

Nurosym and Vagustim are the two auricular tVNS devices users compare when peer-reviewed evidence is the deciding criterion. Both are CE-marked medical devices for ear-clip vagus stimulation (Nurosym’s Class IIa is per the maker); both have real trial bases. The structural difference is programme variety — Nurosym ships a single deliberately-spartan programme, Vagustim layers a library of protocol presets on top.

Nurosym or Vagustim: which is better?

Higher ONDA score: Nurosym (7.4 vs 7.2)

Different philosophies, and Nurosym has the deeper evidence. Nurosym for the spartan single-programme approach with the larger published trial record. Vagustim for protocol-rich auricular tVNS with EU distribution.

Head-to-head breakdown

Nurosym vs Vagustim — head-to-head comparison by criterion
Criterion	Winner	Why
Independent trial evidence	Nurosym	Nurosym: about twenty independent peer-reviewed studies of Parasym devices (50+ according to the manufacturer, as of October 2026), mostly on earlier models. Vagustim: real trial base from Turkish and German collaborator groups but smaller in volume.
Stimulation target	Tie	Both target the auricular branch of the vagus nerve via tragus clip. Same anatomical target.
Stimulation parameters	Tie	Both have known pulse parameters. Nurosym: trials that name it report 20–25 Hz and 200–250 µs; waveform proprietary. Vagustim: parameter ranges per protocol preset.
Protocol variety	Vagustim	Vagustim: library of presets (stress, sleep, depression, anxiety, IBS). Nurosym: single user-titrated programme.
Form factor	Nurosym	Nurosym: single tragus clip. Vagustim: tragus clip plus optional secondary electrode pads for specific protocols. Nurosym is simpler.
Regulatory status	Tie	Both CE-marked medical devices in Europe (Nurosym’s Class IIa per the maker). Neither FDA-cleared.
Brand recognition (outside EU)	Nurosym	Nurosym has broader international brand recognition. Vagustim is primarily EU-focused.
Price	Vagustim	Vagustim: €499 (~$540). Nurosym: €700 (~$820). Vagustim is meaningfully cheaper at the entry tier.

Choose Nurosym

Choose Nurosym if you want the deepest peer-reviewed auricular tVNS evidence base and disclosed parameters — Parasym devices, mostly earlier models, were used in about twenty independent published studies (50+ according to the manufacturer, as of October 2026).

Choose Vagustim

Choose Vagustim if you want auricular tVNS with a wider preset library (stress, sleep, depression, anxiety, IBS), and you are in an EU market where Vagustim ships natively.

The short version

Same anatomy, two different philosophies. Nurosym is the spartan single-programme platform with the deepest evidence base. Vagustim is the protocol-rich EU alternative with broader presets at a lower price.

When is Nurosym the right pick?

If you are running structured tVNS self-experiments, want the deepest published evidence base to reference and prefer a deliberately spartan single-programme approach, Nurosym is the right shape. Parasym devices, mostly earlier models, are the most-studied consumer auricular tVNS platform; the trials that name Nurosym itself were mostly null.

When is Vagustim the right pick?

If you are in an EU market and want a wider library of disclosed-parameter presets covering sleep, stress, depression, anxiety and IBS protocols, Vagustim is the right shape. The lower price and the protocol variety are the differentiators; the trade is brand recognition and trial volume.

Common questions

Should I pick Nurosym or Vagustim?

Nurosym if the deepest published trial base and disclosed-parameter spartan programme are the deciding criteria. Vagustim if you want a wider preset library (sleep, stress, depression, anxiety, IBS) and you are in an EU market with reliable distribution.

Are they on the same nerve target?

Yes — both target the auricular branch of the vagus nerve via a tragus clip. Same anatomy; different stimulation parameter sets and different protocol structures.

Which has more evidence?

Nurosym, on independent trial volume. The Parasym hardware underneath Nurosym, mostly in earlier models, appears in about twenty independent peer-reviewed studies (50+ according to the manufacturer, as of October 2026). Vagustim has a real trial base from Turkish and German collaborator groups but it is smaller — credible, but second-tier on evidence depth.

Is Vagustim a viable Nurosym alternative?

In EU markets, yes — comparable mechanism, comparable regulatory status, broader programme library at a lower price. Outside the EU, brand recognition and customer support are weaker than Nurosym’s.